In one study, the drug reduced blood levels of free PCSK9 protein by more than 90% from baseline when administered to healthy men as a single dose of between 10 and 300 mg, regardless of the dose ...

The company has launched a competition to offer grants of up to $100,000 to multiple projects that can uncover "new insights about the role of the PCSK9 protein/gene in health and disease", with a ...

This is a newer medicine that targets the PCSK9 protein; a molecule made in the liver that circulates through the bloodstream and negatively regulates the metabolism of LDL cholesterol.